These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Application of derivative UV spectrophotometry for the determination of enoxacin and nalidixic acid in tablets. Hopkała H; Kowalczuk D Pharmazie; 2000 Jun; 55(6):432-5. PubMed ID: 10907250 [TBL] [Abstract][Full Text] [Related]
4. [Analysis of the products of drug degradation. XXV. Spectrophotometric method of determination of the content of sodium salt of nalidixic acid (NA-Na)]. Pawelczyk E; Plotkowiak Z Acta Pol Pharm; 1970; 27(2):105-11. PubMed ID: 5422243 [No Abstract] [Full Text] [Related]
5. Gas chromatographic determination of nalidixic acid in tablets. Lung Wu H; Nakagawa T; Uno T J Chromatogr; 1978 Sep; 157():297-302. PubMed ID: 701442 [TBL] [Abstract][Full Text] [Related]
6. Determination of nalidixic acid by fluorometry with sodium borohydride and hydrogen peroxide. Wang ML; Chen SC; Lien JC; Kuo SC J AOAC Int; 2002; 85(3):572-5. PubMed ID: 12083250 [TBL] [Abstract][Full Text] [Related]
7. Application of PMR spectrometry in pharmaceutical analysis, IV. Assay of nalidixic acid. Aboul-Enein HY; Al-Rashood KA; El-Fatatry HM Pharm Acta Helv; 1981; 56(9-10):262-4. PubMed ID: 7291210 [No Abstract] [Full Text] [Related]
10. Qualitative and quantitative tests for nalidixic acid. Salim EF; Shupe IS J Pharm Sci; 1966 Nov; 55(11):1289-90. PubMed ID: 5969788 [No Abstract] [Full Text] [Related]
11. Nalidixic acid and hydroxynalidixic acid analysis in human plasma and urine by liquid chromatography. Shargel L; Koss RF; Crain AV; Boyle VJ J Pharm Sci; 1973 Sep; 62(9):1452-4. PubMed ID: 4582647 [No Abstract] [Full Text] [Related]
12. Assessment of biological properties of implants before their clinical use. Calnan JS Proc R Soc Med; 1970 Nov; 63(11 Part 1):1115-8. PubMed ID: 5484928 [No Abstract] [Full Text] [Related]
13. Nalidixic acid screening test in detection of decreased fluoroquinolone susceptibility in Salmonella typhi isolated from blood. Zafar A; Ibrahim NG; Ahsan T; Abbas Z; Zaidi A; Hasan R J Coll Physicians Surg Pak; 2005 Jul; 15(7):413-7. PubMed ID: 16197870 [TBL] [Abstract][Full Text] [Related]
14. [Fatal nevigramon poisoning]. Tutevich LN; Shershevskiĭ AL; Antakov SS Sud Med Ekspert; 1987; 30(3):54. PubMed ID: 3686618 [No Abstract] [Full Text] [Related]
15. Metabolic behaviour and tissue distribution of nalidixic acid in chickens. Atef M; Youssef SA; Amer AM; el-Bana HA; Hessen RM Dtsch Tierarztl Wochenschr; 1991 Aug; 98(8):303-6. PubMed ID: 1935680 [TBL] [Abstract][Full Text] [Related]
16. Micellar electrokinetic chromatography for determination of drug partition in phospholipids. Quaglia MG; Fanali S; Barbato F; Donati E Farmaco; 2005 Jan; 60(1):77-83. PubMed ID: 15652373 [TBL] [Abstract][Full Text] [Related]
17. Adsorption of the quinolone antibiotic nalidixic acid onto anion-exchange and neutral polymers. Robberson KA; Waghe AB; Sabatini DA; Butler EC Chemosphere; 2006 May; 63(6):934-41. PubMed ID: 16307776 [TBL] [Abstract][Full Text] [Related]
18. Selective decontamination of the digestive tract by norfloxacin. A preliminary report. Pecquet SS; Andremont AO; Tancrède CH Prog Clin Biol Res; 1985; 181():255-8. PubMed ID: 3161086 [No Abstract] [Full Text] [Related]
19. [Prostatic concentrations of norfloxacin using HPLC]. Bologna M; Cavicchio GC; Forchetti CM; Rucci A; Di Nicola G; Vaggi L G Ital Chemioter; 1984; 31(1-2):59-63. PubMed ID: 6236124 [No Abstract] [Full Text] [Related]
20. [Separation and identification of various antibiotics in complex mixtures. IV]. Saccani F; Pitrolo G Boll Chim Farm; 1969 Jul; 108(7):444-8. PubMed ID: 5354280 [No Abstract] [Full Text] [Related] [Next] [New Search]